Bill Activity

Bill Enacted

This bill was enacted into law on 2019-08-06

Contributions

Individuals

There were no contributions to this bill.

You must be logged in to contribute

Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019

This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill

makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program;
allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings;
temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services;
temporarily extends the Medicaid demonstration program for certified community behavioral health clinics;
repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and
increases funding available to the Medicaid Improvement Fund beginning in FY2021.

HR3276-116, S548-116, S2379-116, HR233-116, HR1342-116,

President
Aug. 06 2019	Became Public Law No: 116-39. Signed by President.

Floor
Aug. 01 2019	Presented to President.
Jul. 30 2019	Ms. Norton asked unanimous consent to take from the Speaker's Table and agree to the Senate amendment. (consideration: CR H7477-7478)
Jun. 18 2019	Motion to reconsider laid on the table Agreed to without objection. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333). (text: CR H4706-4707) Considered as unfinished business. (consideration: CR H4751) At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

ResolvingDifferences
Jul. 30 2019	Motion to reconsider laid on the table Agreed to without objection. On motion that the House agree to the Senate amendment Agreed to without objection. (text: CR H7477-7478)

BecameLaw
Aug. 06 2019	Became Public Law No: 116-39. Signed by President.

President
Aug. 01 2019	Presented to President.

NotUsed
Jul. 30 2019	Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text: CR H7477-7478)

Floor
Jul. 25 2019	Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.
Jun. 18 2019	Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333).(text: CR H4706-4707)

Floor
Jul. 25 2019	Message on Senate action sent to the House. Passed Senate with an amendment by Voice Vote. Measure laid before Senate by unanimous consent. (consideration: CR S5114)

IntroReferral
Jun. 19 2019	Received in the Senate, read twice.